Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Omnicell Inc., 3 years.
Omnicell Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2025 | ResMed Inc. | Option exercise | +169 | $146.34 | $24,731 |
| Mar 10, 2025 | ResMed Inc. | Option exercise | +105 | $211.76 | $22,235 |
| Mar 10, 2025 | ResMed Inc. | Option exercise | +3,589 | $146.34 | $525,214 |
| Mar 10, 2025 | ResMed Inc. | Option exercise | +5,882 | $211.76 | $1,245,572 |
| Mar 10, 2025 | ResMed Inc. | Open-market sale | −9,745 | $239.31 | $2,332,076 |
| Mar 3, 2025 | ResMed Inc. | Option exercise | +367 | $211.76 | $77,716 |
| Mar 3, 2025 | ResMed Inc. | Option exercise | +3,506 | $146.34 | $513,068 |
| Mar 3, 2025 | ResMed Inc. | Option exercise | +514 | $146.34 | $75,219 |
| Mar 3, 2025 | ResMed Inc. | Option exercise | +4,726 | $211.76 | $1,000,778 |
| Mar 3, 2025 | ResMed Inc. | Open-market sale | −367 | $235.25 | $86,337 |
| Mar 3, 2025 | ResMed Inc. | Open-market sale | −3,506 | $235.40 | $825,312 |
| Mar 3, 2025 | ResMed Inc. | Open-market sale | −514 | $235.25 | $120,919 |
| Mar 3, 2025 | ResMed Inc. | Open-market sale | −4,726 | $235.43 | $1,112,642 |
| Nov 11, 2024 | ResMed Inc. | Shares withheld for tax | −603 | $252.38 | $152,205 |
| Nov 11, 2024 | ResMed Inc. | Shares withheld for tax | −446 | $252.38 | $112,458 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.